Cargando…
Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
A 64-year-old male patient with metastatic prostate carcinoma diagnosis received lutetium-177 prostate-specific membrane antigen (PSMA) treatment; however, his disease progressed. Herein, presented the final images of the patient that demonstrated a superscan appearance in the Gallium-68 PSMA positr...
Autores principales: | Koç, Zehra Pınar, Özcan, Pınar Pelin, Erçolak, Vehbi, Reyhan, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814547/ https://www.ncbi.nlm.nih.gov/pubmed/35114754 http://dx.doi.org/10.4274/mirt.galenos.2020.78800 |
Ejemplares similares
-
Cancers and Benign Processes on
(68)
Ga PSMA PET-CT Imaging Other than Prostate Cancer
por: Ozcan, Pinar Pelin, et al.
Publicado: (2022) -
Lymphoblastic Involvement of the Bone Marrow as a Cause of Superscan Appearance in (18)F-Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography
por: Koç, Zehra Pınar, et al.
Publicado: (2020) -
Splenosis Mimicking Lymphoma Relapse Confirmed by (18)F-FDG PET/CT and Tc-99m Nano-colloid Scintigraphy Thirty Years After Splenectomy for Trauma
por: Koç, Zehra Pınar, et al.
Publicado: (2019) -
(68)Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
por: de Keizer, Bart, et al.
Publicado: (2016) -
PSMA Expression in Multinodular Thyroid Neoplasm on Simultaneous Ga-68-PSMA PET/MRI
por: Jena, Amarnath, et al.
Publicado: (2017)